Articles with public access mandates - Jason C Kovacic | MBBS, PhD, FRACP, FACC, FSCAI, FAHALearn more
Not available anywhere: 12
The relationships between cardiovascular disease and diabetes: focus on pathogenesis
JC Kovacic, JM Castellano, ME Farkouh, V Fuster
Endocrinology and Metabolism Clinics 43 (1), 41-57, 2014
Mandates: US National Institutes of Health
GuideLiner Mother‐and‐Child Guide Catheter Extension: A Simple Adjunctive Tool in PCI for Balloon Uncrossable Chronic Total Occlusions
JC Kovacic, AB Sharma, S Roy, JR Li, R Narayan, DBIN KIM, SK Sharma, ...
Journal of Interventional Cardiology 26 (4), 343-350, 2013
Mandates: US National Institutes of Health
Outcome of patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention during on-versus off-hours (a Harmonizing Outcomes …
RJ Cubeddu, IF Palacios, JC Blankenship, SA Horvath, K Xu, JC Kovacic, ...
The American Journal of Cardiology 111 (7), 946-954, 2013
Mandates: US National Institutes of Health
The links between complex coronary disease, cerebrovascular disease, and degenerative brain disease
JC Kovacic, JM Castellano, V Fuster
Annals of the New York Academy of Sciences 1254 (1), 99-105, 2012
Mandates: US National Institutes of Health
Patients with 3‐vessel coronary artery disease and impaired ventricular function undergoing PCI with Impella 2.5 hemodynamic support have improved 90‐day outcomes compared to …
JC Kovacic, A Kini, S Banerjee, G Dangas, J Massaro, R Mehran, ...
Journal of Interventional Cardiology 28 (1), 32-40, 2015
Mandates: US National Institutes of Health
Resistant in‐stent restenosis in the drug eluting stent era
K Theodoropoulos, MG Mennuni, GD Dangas, OA Meelu, S Bansilal, ...
Catheterization and Cardiovascular Interventions 88 (5), 777-785, 2016
Mandates: US National Institutes of Health, Leducq Foundation, USA
From treating complex coronary artery disease to promoting cardiovascular health: therapeutic transitions and challenges, 2010–2020
JC Kovacic, V Fuster
Clinical Pharmacology & Therapeutics 90 (4), 509-518, 2011
Mandates: US National Institutes of Health
Aucubin protects against TGFβ1-induced cardiac fibroblasts activation by mediating the AMPKα/mTOR signaling pathway
Y Xiao, W Chang, QQ Wu, XH Jiang, MX Duan, YG Jin, QZ Tang
Planta medica 84 (02), 91-99, 2018
Mandates: National Natural Science Foundation of China
Prevalence and prognostic impact of hsCRP elevation are age‐dependent in women but not in men undergoing percutaneous coronary intervention
M Blum, D Cao, R Chandiramani, R Goel, A Roumeliotis, S Sartori, ...
Catheterization and Cardiovascular Interventions 97 (7), E936-E944, 2021
Mandates: German Research Foundation
Human susceptibility to coronary artery disease: lessons from chimpanzee resilience
GA Figtree, JC Kovacic, HM McGuire
Nature Reviews Cardiology 19 (8), 497-498, 2022
Mandates: US National Institutes of Health, National Health and Medical Research …
Polygenic Risk in Families With Spontaneous Coronary Artery Dissection
I Tarr, S Hesselson, M Troup, P Young, JL Thompson, L McGrath-Cadell, ...
JAMA cardiology 9 (3), 254-261, 2024
Mandates: National Health and Medical Research Council, Australia
Integrative gene regulatory network analysis discloses key driver genes of fibromuscular dysplasia
V d’Escamard, D Kadian-Dodov, L Ma, S Lu, A King, Y Xu, S Peng, ...
Nature Cardiovascular Research 3 (9), 1098-1122, 2024
Mandates: European Commission
Available somewhere: 157
Impact of oxidative stress on the heart and vasculature: part 2 of a 3-part series
T Münzel, GG Camici, C Maack, NR Bonetti, V Fuster, JC Kovacic
Journal of the American College of Cardiology 70 (2), 212-229, 2017
Mandates: US National Institutes of Health, American Heart Association, German …
Endothelial to mesenchymal transition is common in atherosclerotic lesions and is associated with plaque instability
SM Evrard, L Lecce, KC Michelis, A Nomura-Kitabayashi, G Pandey, ...
Nature communications 7 (1), 11853, 2016
Mandates: US National Institutes of Health, Leducq Foundation, USA
Endothelial to Mesenchymal Transition in Cardiovascular Disease: JACC State-of-the-Art Review
JC Kovacic, S Dimmeler, RP Harvey, T Finkel, E Aikawa, G Krenning, ...
Journal of the American College of Cardiology 73 (2), 190-209, 2019
Mandates: US National Institutes of Health, American Heart Association, National …
Epithelial-to-mesenchymal and endothelial-to-mesenchymal transition: from cardiovascular development to disease
JC Kovacic, N Mercader, M Torres, M Boehm, V Fuster
Circulation 125 (14), 1795-1808, 2012
Mandates: US National Institutes of Health, Government of Spain
TGF-β signaling mediates endothelial-to-mesenchymal transition (EndMT) during vein graft remodeling
BC Cooley, J Nevado, J Mellad, D Yang, C St. Hilaire, A Negro, F Fang, ...
Science translational medicine 6 (227), 227ra34-227ra34, 2014
Mandates: US National Institutes of Health
First international consensus on the diagnosis and management of fibromuscular dysplasia
HL Gornik, A Persu, D Adlam, LS Aparicio, M Azizi, M Boulanger, ...
Vascular Medicine 24 (2), 164-189, 2019
Mandates: British Heart Foundation, Doris Duke Charitable Foundation
Oxidative stress and cardiovascular risk: obesity, diabetes, smoking, and pollution: part 3 of a 3-part series
B Niemann, S Rohrbach, MR Miller, DE Newby, V Fuster, JC Kovacic
Journal of the American college of cardiology 70 (2), 230-251, 2017
Mandates: US National Institutes of Health, American Heart Association, German …
Changes in plaque lipid content after short-term intensive versus standard statin therapy: the YELLOW trial (reduction in yellow plaque by aggressive lipid-lowering therapy)
AS Kini, U Baber, JC Kovacic, A Limaye, ZA Ali, J Sweeny, A Maehara, ...
Journal of the American College of Cardiology 62 (1), 21-29, 2013
Mandates: US National Institutes of Health
Publication and funding information is determined automatically by a computer program